Global Drugs for Malaria Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Market by Application
1.3.1 Global Drugs for Malaria Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Malaria Market Perspective (2017-2028)
2.2 Drugs for Malaria Growth Trends by Region
2.2.1 Drugs for Malaria Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Malaria Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Malaria Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Malaria Market Dynamics
2.3.1 Drugs for Malaria Industry Trends
2.3.2 Drugs for Malaria Market Drivers
2.3.3 Drugs for Malaria Market Challenges
2.3.4 Drugs for Malaria Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Malaria Players by Revenue
3.1.1 Global Top Drugs for Malaria Players by Revenue (2017-2022)
3.1.2 Global Drugs for Malaria Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Malaria Revenue
3.4 Global Drugs for Malaria Market Concentration Ratio
3.4.1 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Malaria Revenue in 2021
3.5 Drugs for Malaria Key Players Head office and Area Served
3.6 Key Players Drugs for Malaria Product Solution and Service
3.7 Date of Enter into Drugs for Malaria Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Malaria Breakdown Data by Type
4.1 Global Drugs for Malaria Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Malaria Forecasted Market Size by Type (2023-2028)
5 Drugs for Malaria Breakdown Data by Application
5.1 Global Drugs for Malaria Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Malaria Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Malaria Market Size (2017-2028)
6.2 North America Drugs for Malaria Market Size by Country (2017-2022)
6.3 North America Drugs for Malaria Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Drugs for Malaria Market Size (2017-2028)
7.2 Europe Drugs for Malaria Market Size by Country (2017-2022)
7.3 Europe Drugs for Malaria Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Malaria Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Malaria Market Size by Country (2017-2022)
8.3 Asia-Pacific Drugs for Malaria Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Drugs for Malaria Market Size (2017-2028)
9.2 Latin America Drugs for Malaria Market Size by Country (2017-2022)
9.3 Latin America Drugs for Malaria Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Malaria Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Malaria Market Size by Country (2017-2022)
10.3 Middle East & Africa Drugs for Malaria Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Cipla
11.1.1 Cipla Company Detail
11.1.2 Cipla Business Overview
11.1.3 Cipla Drugs for Malaria Introduction
11.1.4 Cipla Revenue in Drugs for Malaria Business (2017-2022)
11.1.5 Cipla Recent Development
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Company Detail
11.2.2 Guilin Pharmaceutical Business Overview
11.2.3 Guilin Pharmaceutical Drugs for Malaria Introduction
11.2.4 Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2017-2022)
11.2.5 Guilin Pharmaceutical Recent Development
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Company Detail
11.3.2 IPCA Laboratories Business Overview
11.3.3 IPCA Laboratories Drugs for Malaria Introduction
11.3.4 IPCA Laboratories Revenue in Drugs for Malaria Business (2017-2022)
11.3.5 IPCA Laboratories Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Drugs for Malaria Introduction
11.4.4 GlaxoSmithKline Revenue in Drugs for Malaria Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Development
11.5 Mylan Labs
11.5.1 Mylan Labs Company Detail
11.5.2 Mylan Labs Business Overview
11.5.3 Mylan Labs Drugs for Malaria Introduction
11.5.4 Mylan Labs Revenue in Drugs for Malaria Business (2017-2022)
11.5.5 Mylan Labs Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Drugs for Malaria Introduction
11.6.4 Roche Revenue in Drugs for Malaria Business (2017-2022)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Drugs for Malaria Introduction
11.7.4 Novartis Revenue in Drugs for Malaria Business (2017-2022)
11.7.5 Novartis Recent Development
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Company Detail
11.8.2 Sanofi Aventis Business Overview
11.8.3 Sanofi Aventis Drugs for Malaria Introduction
11.8.4 Sanofi Aventis Revenue in Drugs for Malaria Business (2017-2022)
11.8.5 Sanofi Aventis Recent Development
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Company Detail
11.9.2 Ajanta Pharma Business Overview
11.9.3 Ajanta Pharma Drugs for Malaria Introduction
11.9.4 Ajanta Pharma Revenue in Drugs for Malaria Business (2017-2022)
11.9.5 Ajanta Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Aryl Aminoalcohol Compounds
Table 3. Key Players of Antifolate Compounds
Table 4. Key Players of Artemisinin Compounds
Table 5. Global Drugs for Malaria Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Drugs for Malaria Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Drugs for Malaria Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Drugs for Malaria Market Share by Region (2017-2022)
Table 9. Global Drugs for Malaria Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Drugs for Malaria Market Share by Region (2023-2028)
Table 11. Drugs for Malaria Market Trends
Table 12. Drugs for Malaria Market Drivers
Table 13. Drugs for Malaria Market Challenges
Table 14. Drugs for Malaria Market Restraints
Table 15. Global Drugs for Malaria Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Drugs for Malaria Market Share by Players (2017-2022)
Table 17. Global Top Drugs for Malaria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2021)
Table 18. Ranking of Global Top Drugs for Malaria Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Drugs for Malaria Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Drugs for Malaria Product Solution and Service
Table 22. Date of Enter into Drugs for Malaria Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Malaria Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Drugs for Malaria Revenue Market Share by Type (2017-2022)
Table 26. Global Drugs for Malaria Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Drugs for Malaria Revenue Market Share by Type (2023-2028)
Table 28. Global Drugs for Malaria Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Drugs for Malaria Revenue Market Share by Application (2017-2022)
Table 30. Global Drugs for Malaria Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Drugs for Malaria Revenue Market Share by Application (2023-2028)
Table 32. North America Drugs for Malaria Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Drugs for Malaria Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Drugs for Malaria Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Drugs for Malaria Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Drugs for Malaria Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Drugs for Malaria Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Drugs for Malaria Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Drugs for Malaria Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Drugs for Malaria Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Drugs for Malaria Market Size by Country (2023-2028) & (US$ Million)
Table 42. Cipla Company Detail
Table 43. Cipla Business Overview
Table 44. Cipla Drugs for Malaria Product
Table 45. Cipla Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 46. Cipla Recent Development
Table 47. Guilin Pharmaceutical Company Detail
Table 48. Guilin Pharmaceutical Business Overview
Table 49. Guilin Pharmaceutical Drugs for Malaria Product
Table 50. Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 51. Guilin Pharmaceutical Recent Development
Table 52. IPCA Laboratories Company Detail
Table 53. IPCA Laboratories Business Overview
Table 54. IPCA Laboratories Drugs for Malaria Product
Table 55. IPCA Laboratories Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 56. IPCA Laboratories Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Drugs for Malaria Product
Table 60. GlaxoSmithKline Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Mylan Labs Company Detail
Table 63. Mylan Labs Business Overview
Table 64. Mylan Labs Drugs for Malaria Product
Table 65. Mylan Labs Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 66. Mylan Labs Recent Development
Table 67. Roche Company Detail
Table 68. Roche Business Overview
Table 69. Roche Drugs for Malaria Product
Table 70. Roche Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Drugs for Malaria Product
Table 75. Novartis Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Sanofi Aventis Company Detail
Table 78. Sanofi Aventis Business Overview
Table 79. Sanofi Aventis Drugs for Malaria Product
Table 80. Sanofi Aventis Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 81. Sanofi Aventis Recent Development
Table 82. Ajanta Pharma Company Detail
Table 83. Ajanta Pharma Business Overview
Table 84. Ajanta Pharma Drugs for Malaria Product
Table 85. Ajanta Pharma Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 86. Ajanta Pharma Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Drugs for Malaria Market Share by Type: 2021 VS 2028
Figure 2. Aryl Aminoalcohol Compounds Features
Figure 3. Antifolate Compounds Features
Figure 4. Artemisinin Compounds Features
Figure 5. Global Drugs for Malaria Market Share by Application in 2021 & 2028
Figure 6. Prevention Case Studies
Figure 7. Treatment Case Studies
Figure 8. Others Case Studies
Figure 9. Drugs for Malaria Report Years Considered
Figure 10. Global Drugs for Malaria Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Drugs for Malaria Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Drugs for Malaria Market Share by Region: 2021 VS 2028
Figure 13. Global Drugs for Malaria Market Share by Players in 2021
Figure 14. Global Top Drugs for Malaria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Drugs for Malaria Revenue in 2021
Figure 16. North America Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Drugs for Malaria Market Share by Country (2017-2028)
Figure 18. United States Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Drugs for Malaria Market Share by Country (2017-2028)
Figure 22. Germany Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Drugs for Malaria Market Share by Region (2017-2028)
Figure 30. China Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Drugs for Malaria Market Share by Country (2017-2028)
Figure 38. Mexico Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Drugs for Malaria Market Share by Country (2017-2028)
Figure 42. Turkey Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Drugs for Malaria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Cipla Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 45. Guilin Pharmaceutical Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 46. IPCA Laboratories Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 48. Mylan Labs Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 49. Roche Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 50. Novartis Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 51. Sanofi Aventis Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 52. Ajanta Pharma Revenue Growth Rate in Drugs for Malaria Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed